IM-UNITI at Three Years: Stellar Stelara (R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease-MedSci.cn

IM-UNITI at Three Years: Stellar Stelara (R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

Travis, S

Travis, S (corresponding author), Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Translat Gastroenterol Unit, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England.

JOURNAL OF CROHNS & COLITIS, 2020; 14 (1): 1

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

IM-UNITI at Three Years: Stellar Stelara (R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

科室

工具

服务